e-Therapeutics PLC

FRA:3AQ (UK)  
€ 0.09 (0%) May 13
At Loss
P/B:
1.91
Market Cap:
€ 53.17M ($ 57.70M)
Enterprise V:
€ 24.39M ($ 26.47M)
Volume:
-
Avg Vol (2M):
8.00K
Also Trade In:

Business Description

Description
e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 276.06
Equity-to-Asset 0.96
Debt-to-EBITDA -0.01
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 16.74
Distress
Grey
Safe
Beneish M-Score -2
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 34.6
9-Day RSI 38.13
14-Day RSI 38.81
12-1 Month Momentum % -8.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 22.2
Quick Ratio 22.2
Cash Ratio 19.47
Days Sales Outstanding 263.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -29.3
Shareholder Yield % -24.82

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -3721.77
Net Margin % -2957.65
FCF Margin % -3063.08
ROE % -35.52
ROA % -33.9
ROIC % -394.21
ROC (Joel Greenblatt) % -548.47
ROCE % -41.87